Dr. Eytan Stein, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Acute Myeloid Leukemia
Studies Childhood Cancer
14 reported clinical trials
15 drugs studied
Area of expertise
1Acute Myeloid Leukemia
FLT3 positive
IDH positive
U2AF2 positive
2Childhood Cancer
FLT3 positive
IDH positive
Stage IV
Affiliated Hospitals
Clinical Trials Eytan Stein, MD is currently running
SGR-2921
for Leukemia and Preleukemia
The purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) and/or recommended dose (RD) of SGR-2921.
Recruiting1 award Phase 1
Gilteritinib + Ivosidenib/Enasidenib
for Acute Myeloid Leukemia
The researchers are doing this study to see if the combination of gilteritinib with ivosidenib or enasidenib is a safe and effective treatment for people with relapsed/refractory AML with FLT3/IDH1 or FLT3/IDH2 gene mutations. The researchers will also look for the highest dose of the combination of gilteritinib with ivosidenib or enasidenib that causes few or mild side effects. When the highest safe dose is found, they will test that dose in new groups of participants.
Recruiting1 award Phase 1
More about Eytan Stein, MD
Clinical Trial Related1 year of experience running clinical trials · Led 14 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Eytan Stein, MD has experience with
- Enasidenib
- Gilteritinib
- Ivosidenib
- Venetoclax
- Azacitidine
- E7820
Breakdown of trials Eytan Stein, MD has run
Acute Myeloid Leukemia
Childhood Cancer
Granulocytic Leukemia
Myelodysplastic Syndrome
Arterial Tortuosity Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eytan Stein, MD specialize in?
Eytan Stein, MD focuses on Acute Myeloid Leukemia and Childhood Cancer. In particular, much of their work with Acute Myeloid Leukemia has involved FLT3 positive patients, or patients who are IDH positive.
Is Eytan Stein, MD currently recruiting for clinical trials?
Yes, Eytan Stein, MD is currently recruiting for 6 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Eytan Stein, MD has studied deeply?
Yes, Eytan Stein, MD has studied treatments such as Enasidenib, Gilteritinib, Ivosidenib.
What is the best way to schedule an appointment with Eytan Stein, MD?
Apply for one of the trials that Eytan Stein, MD is conducting.
What is the office address of Eytan Stein, MD?
The office of Eytan Stein, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.